DCGI approves Serum & Bharat Biotech COVID-19 vaccines

  • The Central Drugs Standard Control Organisation (CDSCO) has decided to accept the recommendations of its Subject Expert Committee (SEC), and approved the Covid-19 vaccines of both Serum Institute of India and Bharat Biotech for restricted use in the country.
  • Along with that, permission was granted to Cadila Healthcare for the conduct of Phase III clinical trial.

WHAT IS EMERGENCY USE AUTHORISATION?

  • For vaccines and medicines, approval is granted after an assessment of their safety and effectiveness, based on data from trials. 
  • The fastest approval for any vaccine until now — the mumps vaccine in the 1960s — took about four-and-a-half years after it was developed. 
  • In emergency situations, like the current one, regulatory authorities around the world have developed mechanisms to grant interim approvals if there is sufficient evidence.

WHICH ARE THE VACCINES?

  • One vaccine is Covishield, the Indian variant of the AZD1222 vaccine developed by Oxford University and AstraZeneca.
  • It was manufactured by the Serum Institute of India (SII).
  • The other vaccine that has got emergency use authorisation is Covaxin. 
  • It was manufactured by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

WHO WILL BE THE FIRST RECIPIENTS?

  • The first in line will be 30 million (3 crore) workers in the forefront of India’s battle against the novel coronavirus.
  • This will Include 1 crore healthcare workers and 2 crore frontline workers.
  • Also receiving the vaccine in the first phase will be a third priority group – consisting of some 27 crore persons above age 50, and persons below age 50, but with associated comorbidities.
  • The government aims to complete the first phase of vaccinations by August 2021.
CDSCO
  • The Central Drugs Standard Control Organisation (CDSCO) is the national regulatory body of India for pharmaceuticals and medical devices.
  • Headquarters: New Delhi, India.
  • Organisation executive: Dr. V. G. Somani, Drugs Controller General of India.
  • Minister responsible: Harsh Vardhan, Minister of Health and Family Welfare.

Comments

Post a Comment

Popular posts from this blog

Hamas V. PLO

The irony in the ongoing conflict is that Hamas, whose founding members were encouraged by Israel in the 1970s and 80s against Yasser Arafat’s secular national movement, has turned out to be Israel’s biggest rival in the Palestinian territories. HAMAS Hamas was established after the first intifada broke out in 1987, as an offshoot of the Egyptian Muslim Brotherhood.  Intifada was the Palestinian uprising against Israeli occupation of the West Bank and Gaza Strip.  The first intifada lasted from 1987 to 1993, and the second began in 2000. As strife between Israel and Palestine continued to soar as the latter resorted to the First Intifada, or uprising, in December 1987, Hamas as an organisation led by Sunni-Islamic fundamentalists, began to take shape.  Hamas could gain immediate and immense popularity within the protesting Palestinians because it was ...
Read more

G7 global corporate Tax Deal

Image
The Group of Seven (G7) countries have backed the proposal to impose a common global corporate tax. It would be aimed at preventing multinational businesses from evading taxes and also squeeze the havens which attract tax evaders due to the low-rate jurisdictions.  The consensus to adopt a common tax rate was reached at the G7 finance ministers' meeting held in Buckingham (London) on June 5.  THE PROPOSAL The tax proposal endorsed by the US, the UK, France and other G7 countries has two parts.  The main part of the proposal states that countries around the world should tax their home companies' overseas profits at a rate of at least 15%.  The companies have multiple branches spread across various jurisdictions, they transfer the bulk of their profit in accounts set up in countries that offer the lowest tax rate.  Often, these tax havens are the Caribbean Islands such as Bahamas or British Virgin Islands, or at times, countries like Ireland where the corp...
Read more

The statue of Swami Vivekananda at the JNU campus

 Prime Minister Narendra Modi virtually unveiled a life-sized statue of Swami Vivekananda at the Jawaharlal Nehru University (JNU) campus on November 12. JNUSU (JNU students' union), un response, planned to protest on campus.  They believe the Modi government “openly supported” violence on campuses and is attacking universities with the National Education Policy which will result in fund cuts and privatization of education. FUNDING CONTROVERSY It was on June 30, 2017 that JNU’s Executive Council (EC) first gave approval for the statue.  The administration said it was installing the statue to give the campus a more “pleasing look” as Vivekananda had contributed to “nation building”. The administration remained mum on who was funding the statue and how much it would cost.  Then JNU Students’ Union president N Sai Balaji filed several RTIs to know about the funding. In January 2018, he filed an RTI seeking the total cost of construction of the statue as well as the sour...
Read more